Trieu Vuong bought OTLC

January 30, 2025 · Form 4 insider transaction

Trieu Vuong bought 100,003 shares of Oncotelic Therapeutics, Inc. at $0.03 per share, a transaction worth $2.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.